A 62-year-old man from Mumbai presents with a 3-month history of painless progressive jaundice, pale stools, and dark urine. He denies abdominal pain, weight loss, or fever. On examination, he is icteric with a palpable gallbladder. Abdominal ultrasound shows dilated intrahepatic bile ducts, a dilated common bile duct (12 mm), and a hypoechoic lesion in the pancreatic head (2.5 cm). Liver function tests show total bilirubin 8.2 mg/dL (direct 7.8 mg/dL), alkaline phosphatase 420 IU/L, and ALT 95 IU/L. CT abdomen with contrast confirms a 2.5 cm mass in the pancreatic head with upstream ductal dilatation. CA 19-9 is elevated at 185 U/mL. What is the most appropriate next step in management?

Explanation

## Clinical Context This is a classic presentation of **pancreatic head cancer with obstructive jaundice**. The key findings are: - Painless progressive jaundice (Courvoisier sign: palpable gallbladder) - Dilated intrahepatic and common bile ducts - Hypoechoic pancreatic head lesion on imaging - Elevated CA 19-9 ## Management Algorithm for Resectable Pancreatic Cancer with Obstructive Jaundice ```mermaid flowchart TD A[Pancreatic head cancer + obstructive jaundice]:::outcome --> B{Bilirubin > 5 mg/dL?}:::decision B -->|Yes| C[Preoperative biliary drainage]:::action C --> D[ERCP with plastic stent]:::action D --> E[Allow 4-6 weeks for jaundice resolution]:::action E --> F[Complete staging: CT chest, consider EUS]:::action F --> G{Resectable?}:::decision G -->|Yes| H[Whipple pancreaticoduodenectomy]:::action G -->|No| I[Palliative chemotherapy]:::action B -->|No| J[Proceed directly to staging]:::action ``` ## Why ERCP with Stent is Correct **Key Point:** Preoperative biliary drainage is indicated when total bilirubin >5 mg/dL (here 8.2 mg/dL) to: 1. Reduce perioperative morbidity and mortality 2. Allow coagulopathy and synthetic function to recover 3. Reduce risk of cholangitis during staging 4. Permit adequate nutritional optimization **High-Yield:** ERCP is the first-line drainage modality in pancreatic head cancer because: - Success rate >90% for distal CBD obstruction - Allows tissue sampling (brushings, biopsy) - Plastic stent preferred over metal (allows future ERCP if needed) - Lower morbidity than PTC in this setting **Clinical Pearl:** After stent placement, wait 4–6 weeks for jaundice to resolve and coagulation to normalize before surgery. This improves operative outcomes. ## Staging After Drainage **Key Point:** After ERCP and resolution of jaundice, complete staging includes: - CT chest (metastases, distant disease) - Endoscopic ultrasound (EUS) for local staging and tissue diagnosis - Assessment of vascular involvement (superior mesenteric vessels, portal vein) ## Resectability Criteria A 2.5 cm head lesion with upstream ductal dilatation is potentially resectable if: - No distant metastases - No major vascular involvement (SMV, PV, celiac axis) - Performance status adequate **Mnemonic: RESECTABLE pancreatic cancer** — **R**esectable if <180° contact with SMV/PV, **E**xtrahepatic bile duct involved (still resectable), **S**mall tumor, **E**arly stage, **C**lear margins achievable, **T**umor in head/body, **A**denosquamous histology (worse), **B**iliary obstruction (manageable), **L**ow CA 19-9 (better), **E**arly detection. [cite:Harrison 21e Ch 297]